Physician profile
David Eric Negron
NPI 1285623694
$2,176.77
in general payments reported to CMS, 2019-2025
13 companies · $342 in 2025
The $342 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2022: $28.89 · 2023: $401 · 2024: $1,261 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,100 · Travel and Lodging: $903.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,099.69 |
| Travel and Lodging | $903.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $1,132.14 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Smith+Nephew, INC. | $489.18 | 2022-2025 | Grafix Pl, Stravix, Grafix Xc |
| Bone Support INC. | $262.22 | 2024 | Cerament G, Ceramentbone Void Filler |
| Organogenesis INC. | $117.72 | 2019 | |
| Shionogi INC | $32.84 | 2025 | Fetroja |
| Misonix INC | $26.98 | 2019 | |
| Reapplix INC. | $26.44 | 2025 | 3c Patch Kit - Box |
| Lifenet Health | $19.40 | 2023 | |
| Next Science LLC | $18.97 | 2023 | Surgx, Blastx, Xperience |
| Medtronic, INC. | $16.25 | 2023 | Venaseal |
| Access Pro Medical, LLC | $14.99 | 2022 | |
| Solventum Corporation | $13.70 | 2025 | Activ.A.C. |
| Advanced Oxygen Therapy INC. | $5.94 | 2025 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Negron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.